Sign in

Ben Hale

@benhale.bsky.social
1K followers 210 following 18 posts

Professor of Medical Virology, University of Zurich, Switzerland. My research group studies molecular mechanisms of the interferon system, interferon deficiencies, and viral disease.

PostsRepliesMedia
Ben Hale @benhale.bsky.social · 21/09/2026
Congrats to Samira Schiefer on her new paper in Science Advances! We analysed 70 natural human IFNB1 variants & found both loss- & gain-of-function IFNβ proteins, revealing unexpected diversity in antiviral immunity. Great effort with Dave Jones & Florence Kwaschik! www.science.org/doi/10.1126/...
science.org
Functional diversity of natural human IFNB1 variants in innate immunity
Human interferon-β (IFN-β), a type I IFN, is critical for effective innate immunity and is also an approved disease-modifying therapeutic. While genetic variations in several components of the type I ...
0128
Ben Hale @benhale.bsky.social · 08/05/2026
Nice to see that our own Institute of Medical Virology @virology.uzh.ch could contribute to the first genetic sequencing of the Andes hantavirus strain from the ongoing cruise ship outbreak. @med.uzh.ch @uzh-ch.bsky.social
140
Ben Hale @benhale.bsky.social · 08/05/2026
‘Influenza A virus NS1 sequesters RNA:DNA hybrids to evade RNase H1-dependent innate immunity' - a project from Florence Kwaschik, who defends her PhD in a few months, is now preprinted. Thank-you to co-authors Ian Pichler, José Ruiz, Verena Kufner & Michael Huber. www.biorxiv.org/content/10.6...
biorxiv.org
0137
Reposted by Ben Hale
Casanova Lab @casanovalab.bsky.social · 07/05/2026
15/ Finally, @benhale.bsky.social showed in a beautiful longitudinal study that once they appear, auto-Abs neutralizing type I IFNs persist and diversify (rupress.org/jem/article/...).
rupress.org
Loss of tolerance precedes triggering and lifelong persistence of pathogenic type I interferon autoantibodies
Rare autoantibodies neutralizing type I IFNs can underlie viral disease severity. Here, the authors dissect immunological and age-related factors associate
121
Ben Hale @benhale.bsky.social · 08/05/2026
Pleased to have contributed to this work by providing samples from the Swiss HIV Cohort Study - a powerful longitudinal biobank that has been running for almost 40 years & which is an amazing resource for studying both HIV pathogenesis & many other aspects of aging biology in human health & disease
010
Reposted by Ben Hale
Casanova Lab @casanovalab.bsky.social · 06/05/2026
15/ Finally, @benhale.bsky.social showed in a beautiful longitudinal study that once they appear, auto-Abs neutralizing type I IFNs persist and diversify (rupress.org/jem/article/...).
rupress.org
Loss of tolerance precedes triggering and lifelong persistence of pathogenic type I interferon autoantibodies
Rare autoantibodies neutralizing type I IFNs can underlie viral disease severity. Here, the authors dissect immunological and age-related factors associate
131
Reposted by Ben Hale
Ben Hale @benhale.bsky.social · 25/03/2026
🔬 We’re hiring in Zürich🇨🇭! My lab is recruiting a new PhD student in molecular immunology (interferons, autoantibodies & viral disease). Position is fully-funded. Starting date anticipated to be late 2026/early 2027. Further details and how to apply: tinyurl.com/IMVPhD2026 Deadline 1st May 2026.
tinyurl.com
PhD Studentship in Molecular Immunology (interferons in health and disease)
038
Ben Hale @benhale.bsky.social · 25/03/2026
🔬 We’re hiring in Zürich🇨🇭! My lab is recruiting a new PhD student in molecular immunology (interferons, autoantibodies & viral disease). Position is fully-funded. Starting date anticipated to be late 2026/early 2027. Further details and how to apply: tinyurl.com/IMVPhD2026 Deadline 1st May 2026.
tinyurl.com
PhD Studentship in Molecular Immunology (interferons in health and disease)
038
Ben Hale @benhale.bsky.social · 03/02/2026
In a new article with Kevin Groen, we review the most recent scientific developments relating to autoantibodies targeting type I interferons and their impacts on severe viral disease: doi.org/10.1016/j.co...
076
Reposted by Ben Hale
Journal of Human Immunity @jhumimmunity.org · 19/01/2026
Increased prevalence of #autoantibodies neutralizing IFNλ2/3 in young individuals with #CysticFibrosis. New report from Kevin Groen, Emanuela Bruscia, Marc Emmenegger, Benjamin Hale @benhale.bsky.social and colleagues: rupress.org/jhi/article/... #Autoimmunity #Infections
096
Ben Hale @benhale.bsky.social · 15/01/2026
Happy to join @jem.org as an Associate Editor for 2026 and to contribute to the journal’s publishing process and community!
072
Reposted by Ben Hale
Journal of Human Immunity @jhumimmunity.org · 12/01/2026
Groen, @benhale.bsky.social et al. @virology.uzh.ch identify interferon-λ #autoantibodies in 11.8% of those with #CysticFibrosis, a prevalence >10-fold higher than expected. In vitro & clinical analyses suggest the antibodies may impact mucosal pathology. rupress.org/jhi/article/...
064
Reposted by Ben Hale
Journal of Experimental Medicine @jem.org · 08/01/2026
Type I interferon autoantibody footprints reveal neutralizing mechanisms and allow inhibitory decoy design. From Kevin Groen, Benjamin Hale (@benhale.bsky.social) and colleagues 👉 rupress.org/jem/article/... 📘 Part of 2025: The Year in Experimental Medicine rupress.org/jem/collecti... #Autoimmunity
042
Ben Hale @benhale.bsky.social · 17/12/2025
Nice to see our study led by Kevin Groen included in the 2025 ‘Best of JEM’. We dissected the mechanisms by which pathogenic autoantibodies block IFN-I function and used the information to design decoy molecules that might form the basis for future therapies. rupress.org/jem/article/...
rupress.org
Type I interferon autoantibody footprints reveal neutralizing mechanisms and allow inhibitory decoy design | Journal of Experimental Medicine | Rockefeller University Press
Autoantibodies neutralizing IFN-Is exacerbate severe viral diseases such as COVID-19. Here, the authors identify IFN-I regions commonly targeted by these a
073
Reposted by Ben Hale
Sam J Wilson @samjwilsonphd.bsky.social · 27/11/2025
How does fever work? Our new Science paper shows how elevated body temperature can protect against severe influenza and that avian-origin viruses escape this defence. This is likely one reason why bird flus and some pandemic influenzas can be so severe.🧵 www.science.org/doi/10.1126/...
science.org
Avian-origin influenza A viruses tolerate elevated pyrexic temperatures in mammals
Host body temperature can define a virus’s replicative profile—influenza A viruses (IAVs) adapted to 40° to 42°C in birds are less temperature sensitive in vitro compared with human isolates adapted t...
620089
Ben Hale @benhale.bsky.social · 05/11/2025
I very much enjoyed my time in St Andrews, Scotland as a PhD student. If I was still considered an Early-Career Researcher just starting my own laboratory (in my head, I am!), I would certainly be interested in this fellowship opportunity...
021
Ben Hale @benhale.bsky.social · 26/09/2025
Thank-you @casanovalab.bsky.social for the kind invitation to be a participant at your celebratory Novo Nordisk Prize Symposium. I appreciated being able to present alongside a great array of leading researchers, & to meet so many welcoming people in the field of Inborn Errors of Immunity! Congrats!
140
Ben Hale @benhale.bsky.social · 09/09/2025
'TRIM28 is a target for paramyxovirus V proteins'. Work led by Gauthier Lieber seeks to address whether host activation of endogenous retroelements contributes to antiviral defences. In support of this idea, he describes a viral mechanism that might limit this host response. doi.org/10.1371/jour...
doi.org
TRIM28 is a target for paramyxovirus V proteins
Author summary Host recognition of viral nucleic acids is fundamental for stimulating antiviral immunity. To prevent aberrant immune activation, cells must precisely differentiate “non-self” from “sel...
054
Reposted by Ben Hale
EMBO Reports @emboreports.org · 16/06/2025
Regulated localization of transposable element #RNA during #influenza A #virus #infection. -> www.embopress.org/doi/full/10....
021
Ben Hale @benhale.bsky.social · 16/06/2025
Now in press: Marie Lork & our collaborators studied host transposable elements during influenza A virus infection. We found evidence that some produce dsRNA, but that these host dsRNAs are limited from reaching the cytosol by the viral NS1 protein. @emboreports.org www.embopress.org/doi/full/10....
embopress.org
Regulated localization of transposable element RNA during influenza A virus infection | EMBO reports
imageimageInfluenza A virus infection increases host transposable element (TE) expression. This study provides evidence that some infection-induced TEs form double-stranded RNAs that accumulate in the...
0209
Reposted by Ben Hale
David Bhella @dbhella.bsky.social · 20/05/2025
A nice photo from last week’s ’Celebration of 50 years of Virology’ in St Andrews - marking a milestone in the distinguished career of Rick Randall - a great virologist, colleague and friend - congratulations Rick!
1161
Ben Hale @benhale.bsky.social · 22/04/2025
Anti-interferon autoantibodies are always on my mind....even at Easter!
030
Reposted by Ben Hale
Journal of Experimental Medicine @jem.org · 27/03/2025
Type I interferon autoantibody footprints reveal neutralizing mechanisms and allow inhibitory decoy design. New study from Kevin Groen, Benjamin Hale (@benhale.bsky.social) and colleagues @virology.uzh.ch: rupress.org/jem/article/... #Autoimmunity #Immunodeficiency #InfectiousDisease
1126
Reposted by Ben Hale
Waggoner Lab @labwaggoner.bsky.social · 27/03/2025
An atlas of protein phosphorylation dynamics during interferon signaling @benhale.bsky.social www.pnas.org/doi/10.1073/...
0213
Reposted by Ben Hale
Institute of Medical Virology, University Zurich @virology.uzh.ch · 26/03/2025
A follow up on @benhale.bsky.social and colleagues' research published in @jem.org : How "decoy molecules" intercept harmful auto-antibodies, restoring antiviral immunity. www.news.uzh.ch/en/articles/...
news.uzh.ch
Decoys Restore Antiviral Immune Defense
141
Reposted by Ben Hale
Journal of Experimental Medicine @jem.org · 20/03/2025
AutoAbs neutralizing IFN-Is exacerbate severe viral diseases. Groen, @benhale.bsky.social et al. @virology.uzh.ch identify IFN-I regions commonly targeted by these autoAbs and develop a proof-of-concept decoy strategy to alleviate pathogenic effects. rupress.org/jem/article/...
1104
Ben Hale @benhale.bsky.social · 05/03/2025
Interferon research has a long history at the University of Zurich, Switzerland. Charles Weissmann, Professor of Molecular Biology, led the group that first cloned interferon genes. This allowed large-scale production and facilitated the medical use of interferon. @uzh-ch.bsky.social
081
Ben Hale @benhale.bsky.social · 20/11/2024
In our most recent work, Kevin Groen from the lab made AIR cells for rapid & sensitive functional detection of interferon types I, II & III. AIR cells can be used with a live cell luciferase substrate, are highly sensitive & can detect autoantibodies neutralising interferons. doi.org/10.1002/eji....
doi.org
Highly sensitive reporter cell line for detection of interferon types I–III and their neutralization by antibodies
Interferons (IFNs) are a critical component of innate immune defenses and limit viral disease severity. To advance studies on IFNs and their neutralization by pathogenic autoantibodies, we generated ...
0121
Ben Hale @benhale.bsky.social · 28/05/2024
Congratulations to Samira Schiefer from the lab whose use of proximity proteomics to comprehensively survey and characterise the type I interferon signalling pathway has just been published. Many new associations found. www.nature.com/articles/s41...
nature.com
Proximal protein landscapes of the type I interferon signaling cascade reveal negative regulation by PJA2 - Nature Communications
Type I IFN is vital for antiviral defense. Here, the authors use TurboID-based proximity labeling to comprehensively map the protein landscapes surrounding core IFN signaling members. Among factors un...
020